Search
Search
mobile logo
Title Image

LSK BioPharma at ASCO 2015

RELATED POSTS

Elevar Therapeutics Announces Expansion of Senior Leadership Team with Key Appointments in Clinical and Finance Functions
Elevar Therapeutics Announces Appointment of Jenny Gizzi to Chief People Officer
Elevar Therapeutics Receives Orphan Drug Designation from FDA for Rivoceranib for the Treatment of Hepatocellular Carcinoma (HCC)
Elevar Therapeutics Announces New Appointments to its Board of Directors

Salt Lake City, UT    |    San Francisco, CA    |    Dublin, Ireland    |    Seoul, South Korea

© Copyright 2021 Elevar Therapeutics